ストックスクリーナーアプリを入手
6.825
7.36%
0.445
前日終値:
$6.38
開ける：
$6.37
24時間の取引高:
1.54M
Relative Volume:
0.86
時価総額：
$1.18B
収益：
$25.55M
当期純損益:
$-341.97M
株価収益率:
-2.4375
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
+8.89%
1か月 パフォーマンス:
-2.71%
6か月 パフォーマンス:
+139.49%
1年 パフォーマンス:
+47.62%
1日の値動き範囲:
$6.28
$6.86
1週間の範囲:
$6.17
$6.86
52週間の値動き範囲:
$1.775
$7.64
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
6.825 | 1.11B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.11 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.62 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.90 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.18 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-04 | 再開されました | Guggenheim | Buy |
| 2025-04-17 | 開始されました | Wells Fargo | Equal Weight |
| 2024-09-10 | 再開されました | Goldman | Buy |
| 2024-09-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
| 2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 開始されました | Raymond James | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-09-30 | 開始されました | Barclays | Equal Weight |
| 2022-09-02 | 開始されました | Stifel | Buy |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-07-21 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-10 | 開始されました | Cowen | Outperform |
| 2020-08-10 | 開始されました | Goldman | Buy |
| 2020-08-10 | 開始されました | Guggenheim | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Should I hold or sell Relay Therapeutics Inc. stock in 2025CEO Change & AI Based Buy and Sell Signals - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly data2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum playJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Relay Therapeutics Inc. (RLAY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Commit To Buy Relay Therapeutics At $5, Earn 22.4% Annualized Using Options - Nasdaq
Citizens reiterates Market Outperform rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
What analysts say about Relay Therapeutics Inc stockChart Pattern Recognition & Outstanding Growth Strategies - earlytimes.in
How Relay Therapeutics Inc. stock compares to growth peersTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Relay Therapeutics Inc. stock positioned for long term growth - newser.com
Does Relay Therapeutics Inc. show high probability of reboundProduct Launch & Reliable Price Action Trade Plans - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesShare Buyback & Growth Focused Stock Reports - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com
Relay Therapeutics Q3 2025 Earnings Preview - MSN
Why Relay Therapeutics Inc. stock is trending among retail traders2025 Trading Recap & Free Community Supported Trade Ideas - Fundação Cultural do Pará
What machine learning models say about Relay Therapeutics Inc.2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Why retail investors favor Relay Therapeutics Inc. stockQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
How to use a screener to detect Relay Therapeutics Inc. breakoutsShare Buyback & Safe Swing Trade Setups - newser.com
Will Relay Therapeutics (RLAY) Board Additions Signal a Shift in Commercialization Strategy? - Yahoo Finance
Relay Therapeutics Inc Stock Analysis and ForecastTrend Following Strategies & Minimal Capital Growth Plans - earlytimes.in
Regression analysis insights on Relay Therapeutics Inc. performanceDollar Strength & AI Powered Market Entry Ideas - newser.com
Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Why hedge funds are buying Relay Therapeutics Inc. stockMarket Volume Summary & Consistent Return Investment Signals - newser.com
Has Relay Therapeutics Inc. found a price floor2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Relay Therapeutics Trims Costs And Stays Well-Funded - Finimize
Full technical analysis of Relay Therapeutics Inc. stockMarket Rally & Safe Entry Trade Reports - newser.com
Wells Fargo Maintains Relay Therapeutics (RLAY) Equal-Weight Recommendation - Nasdaq
Relay Therapeutics (RLAY) Analyst Rating Update by Wells Fargo | RLAY Stock News - GuruFocus
Relay Therapeutics Reports Q3 2025 Financial Progress - TipRanks
Decoding Relay Therapeutics Inc (RLAY): A Strategic SWOT Insight - GuruFocus
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 - Investing News Network
Relay Therapeutics (RLAY) Advances Clinical Trials in Breast Can - GuruFocus
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - Investing News Network
Relay Therapeutics Inc Reports Q3 2025 EPS of -$0.43, Revenue at $0, Missing Estimates - GuruFocus
Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029 - TradingView
Relay Therapeutics Appoints Two New Board Members - TradingView
[10-Q] Relay Therapeutics, Inc. Quarterly Earnings Report | RLAY SEC FilingForm 10-Q - Stock Titan
[8-K] Relay Therapeutics, Inc. Reports Material Event | RLAY SEC FilingForm 8-K - Stock Titan
RLAY: Clinical progress, reduced losses, and strong cash position support operations into 2029 - TradingView
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
Relay Therapeutics Inc (RLAY) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):